Atlas Trials

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Clinical trial NCT02085967 · COMPLETED

Trial details

NCT number
NCT02085967
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2014-02-01
Primary completion
2014-04-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.